Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Deferred Taxes (2020 - 2021)

Historic Deferred Taxes for Neurocrine Biosciences (NBIX) over the last 2 years, with Q4 2021 value amounting to -$4.7 million.

  • Neurocrine Biosciences' Deferred Taxes rose 9848.73% to -$4.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $4.3 million, marking a year-over-year increase of 10138.4%. This contributed to the annual value of -$123.1 million for FY2024, which is 11710.76% down from last year.
  • Latest data reveals that Neurocrine Biosciences reported Deferred Taxes of -$4.7 million as of Q4 2021, which was up 9848.73% from $5.7 million recorded in Q3 2021.
  • Neurocrine Biosciences' Deferred Taxes' 5-year high stood at $9.5 million during Q2 2021, with a 5-year trough of -$310.7 million in Q4 2020.